Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Zalicus Inc | 30 |
| 2 | Fred Hutchinson Cancer Center | 19 |
| 3 | Follica Inc | 8 |
| 4 | Penwest Pharmaceuticals Co | 7 |
| 5 | Angiotech International AG | 5 |
| 6 | Puretech Ventures LLC | 4 |
| 7 | University of Pennsylvania | 3 |
| 8 | Organon Pharma UK Ltd | 2 |
| 9 | Agilent Technologies Inc | 1 |
| 10 | Bayer Oy | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 61 |
| 2 | A61P | Therapeutic activity (drug indications) | 46 |
| 3 | A01N | Preservation of bodies; biocides; pest repellents | 17 |
| 4 | C12N | Microorganisms, enzymes | 14 |
| 5 | A61M | Devices for introducing media into the body | 11 |
| 6 | Y02A | Climate change adaptation | 7 |
| 7 | A61B | 6 | |
| 8 | A61Q | Cosmetics, personal care | 6 |
| 9 | A61F | 5 | |
| 10 | A61L | Sterilising / disinfecting materials | 5 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | A Posner | Harlem Hospital Center | 1 |
| 2 | A S RIVERO | 1 | |
| 3 | ANDRES I. REYES | Maimonides Medical Center | 1 |
| 4 | Abdelwahab Ahmed | McGill University | 1 |
| 5 | Adam J. Krakowski | Champlain Valley Physicians Hospital | 1 |
| 6 | Albert Elmsjö | Swedish National Board of Forensic Medicine | 1 |
| 7 | Anna Axmon | Lund University | 1 |
| 8 | Anna Nordström | Umeå University | 1 |
| 9 | Birgitta Jonasson | Uppsala University | 1 |
| 10 | Bradley E. Smith | St Albans City Hospital | 1 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Prescription of potentially inappropriate medications among older people with intellectual disability: a register study | 2017 | 41 | Heart Failure Treatment and Management |
| Propiomazine Hydrochloride in Obstetrical Analgesia | 1962 | 21 | Anesthesia and Pain Management |
| Effect of organic modifiers on retention and enantiomeric separations by capillary electrophoresis with human serum albumin as a chiral selector in solution | 1997 | 19 | Microfluidic and Capillary Electrophoresis Applications |
| Use of short-acting and long-acting hypnotics and the risk of fracture: a critical analysis of associations in a nationwide cohort | 2019 | 9 | Schizophrenia research and treatment |
| Maternal-fetal effects of propiomazine-meperidine analgesia | 1962 | 8 | Anesthesia and Pain Management |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Largon?
Which organizations hold the most patents involving Largon?
What are the main patent classification areas for Largon-related inventions?
What historical research has been published on Largon's clinical applications?
How has research activity on Largon changed in recent years?